68ga-dotanoc and Empty-Sella-Syndrome

68ga-dotanoc has been researched along with Empty-Sella-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for 68ga-dotanoc and Empty-Sella-Syndrome

ArticleYear
Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET/CT.
    Japanese journal of radiology, 2012, Volume: 30, Issue:9

    Patients with multiple endocrine neoplasia type-1 syndromes are known to have neuroendocrine tumors (NETs) involving the pituitary and gastroenteropancreatic region, in addition to the presence of parathyroid abnormalities. In rare instances adenomas in the ectopic pituitary gland have been reported. As pituitary gland and pituitary adenomas are known to express SSTRs, somatostatin receptor scintigraphy can be used for imaging. Somatostatin receptor-based PET/CT imaging using 68Ga-DOTANOC has become a popular noninvasive imaging modality for evaluation of patients with NETs. The application of 68Ga-DOTANOC PET/CT can be extended to multiple endocrine neoplasia type 1 patients, as is evident from this case study.

    Topics: Aged; Choristoma; Duodenal Diseases; Empty Sella Syndrome; Female; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Organometallic Compounds; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed

2012